Caribou Biosciences believes it has developed a ready-made CAR-T therapy that’s on par with currently available custom-made treatments for blood cancer, succeeding where other cell therapy makers have largely failed. Such a treatment could represent …
AI Developed Code: 5 Critical Security Checkpoints for Human Oversight
To write secure code with LLMs developers must have the skills to use AI as a collaborative assistant rather than an autonomous tool, Madou argues.
Roche, Manifold Bio to advance new brain shuttles in pact worth up to $2B+
As Roche kicks off Phase 3 studies for its “Brainshuttle” Alzheimer’s drug, it’s also hunting for the next best way to get drugs into the brain. On Monday, the Swiss pharma company announced a research …
BioNTech ups sales guidance after Bristol Myers’ bispecific payment
BioNTech was able to raise its full-year guidance due to a windfall from its PD-1xVEGF bispecific collaboration with Bristol Myers Squibb. The German biotech said in its third-quarter earnings Monday that it now expects to …
Pharma’s corporate reputation dips among neurology patient groups, citing drug access challenges
Neurology-focused patient groups’ perception of the pharma industry’s corporate reputation remains on a downward slope.
CDER head Tidmarsh ‘on leave’ and is sued by drugmaker
George Tidmarsh is no longer at the helm of CDER and is facing a lawsuit claiming he abused his position there to harm a former business associate.
‘TruffleNet’ Attack Wields Stolen Credentials Against AWS
Reconnaissance and BEC are among the malicious activities attackers commit after compromising cloud accounts, using a framework based on the TruffleHog tool.
Free Wegovy trialled in deprived areas of Scotland
Thousands of people from Scotland’s most deprived areas will get free weight-loss jabs in a real-world study to gauge if they can save the NHS money.
Generative AI in clinical (2020–2025): a mini-review of applications, emerging trends, and clinical challenges
Generative artificial intelligence (G-AI) has moved from proof-of-concept demonstrations to practical tools that augment radiology, dermatology, genetics, drug discovery, and electronic-health-record analysis. This mini-review synthesizes fifteen studies published between 2020 and 2025 that collectively illustrate three dominant trends: data augmentation for imbalanced or privacy-restricted datasets, automation of expert-intensive tasks such as radiology reporting, and generation […]
Amgen Ventures joins $141M Series B for Italian gene therapy biotech AAVantgarde
A Milan-based drugmaker has secured $141 million in a Series B raise backed by Amgen to develop gene therapies for two inherited retinal diseases that cause blindness. AAVantgarde said it will use the funds to …